Executive Functions in Adults With Congenital Heart Disease
NCT ID: NCT04041557
Last Updated: 2019-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2017-01-01
2018-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aims:
1. To determine intellectual and executive functions in young adults with congenital heart disease after childhood cardiopulmonary bypass surgery and to relate these findings to results on cerebral magnetic resonance imaging (MRI).
2. To evaluate risk factors for adverse outcome and alteration on cerebral MRI.
3. To examine the effect of poorer intellectual and executive functioning on academic achievement, quality of life, and psychosocial functioning.
Methodology:
Outcome variables: Intellectual and executive functioning as well as cerebral MRI.
Participants: Study subjects will be recruited from a large cohort that has been enrolled in a study on quality of life in ACHD. The investigators aim to include a maximum of 60 subjects per group (ACHD, controls). Variables and risk factors influencing outcome have already been assessed through that study. Cerebral MRI will be analysed for structural abnormalities, and volumetric, morphometric as well as connectivity analyses will be performed to comprehensively characterize cerebral architecture in ACHD and to compare it with that of healthy controls.
Inclusion criteria: Patients with congenital heart disease, cardiopulmonary bypass surgery during childhood, age 18 to 30 years Exclusion criteria: Known genetic syndromes or chromosomal abnormalities as well as other congenital or acquired diseases leading to mental disabilities, exclusion criteria for cerebral MRI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Function in Children With Congenital Heart Disease (CHD)
NCT02814539
Neurodevelopment in Infants With Complex Congenital Heart Defects
NCT03104751
The Swiss Neurodevelopmental Outcome Registry for Children With CHD
NCT05996211
Predictive Value of Neurovascular Coupling in Infants With COngenital Heart Disease
NCT06190210
NEUROlogical Prognosis After Cardiac Arrest in Kids
NCT03574025
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific aims:
1. To determine the intellectual and executive function of young adults with congenital heart disease after cardiopulmonary bypass surgery during infancy or childhood Hypothesis: Intellectual outcome is within the normal range but below that of controls and assume to find specific difficulties in certain areas of executive functions.
2. To perform cerebral MRI and perform morphometric analyses Hypothesis: Cerebral volumes will be smaller and regional white matter microstructure will be altered, which correlate with intellectual and executive function
3. To determine patient and medical risk factors associated with adverse outcome Hypothesis: Disease severity correlates with intellectual outcome.
4. To determine the associations between intellectual and executive function and quality of life Hypothesis: Functional outcome correlates with quality of life.
Subjects:
The patients and controls have participated in a study on quality of life in adults with CHD and will be asked to return for this part of the study. So far, 180 patients and 145 controls have been enrolled.
Inclusion Criteria:
* Patients with congenital heart disease
* Bypass surgery for congenital heart disease
* Male and female subject 18 to 30 years of age
* Written informed consent by the participant after information about the project
* In command of the German language
* No exclusion criteria for cerebral MRI
Exclusion Criteria:
* Known genetic syndromes or chromosomal abnormalities as well as other congenital or acquired diseases leading to mental disabilities
* Exclusion criteria for cerebral MRI
Outcome measures:
Intelligence will be assessed with the Wechsler Adult Intelligence Scale IV edition.
A large battery using standardized tests will be administered for the executive function assessment. This includes the following domains: Working and visual memory, inhibition, flexibility, planning, fluency, attention and questionnaires will assess the everyday functioning regarding executive functions (behavior rating inventory of executive functions-BRIEF).
Medical and sociodemographic data These data have already been obtained by the ongoing study.
Cerebral MRI MRI will be performed with a 3.0-T whole-body system (Signa Twinspeed Excite; GE Healthcare, Milwaukee, Wisconsin). Three-dimensional anatomic images of the entire brain will be obtained using a T1-weighted gradient echo pulse sequence (repetition time, 25 msec; echo time, 5 msec) and a T2-weighted spin echo pulse sequence (repetition time,6660 msec; echo time, 97.6 msec).
Time schedule Recruitment and testing phase 6-9 months, data entry, data control and preliminary data analysis 3 months.
Start of the project: January 1st, 2017, duration: 1 year.
Statistical Plan The sample size estimated is 51 participants per group given a two-sided alpha of 0.05 and a power of 90% resulting in a total of 102 participants for the study. In order to control for drop-outs, each group will comprise 60 subjects. Data will be analyzed using SPSS statistic software version 23 (SPSS inc., Chicago). Parametric or non-parametric procedures will be used to compare patients and controls with regard to outcome variables. To examine the role of predictors for the outcomes multivariate regression analyses will be performed.
Ethics Ethical approval is available for the assessment of neurocognitive and executive functions. An amendment is currently being submitted for the cerebral MRI part.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adults with CHD
Adults with congenital heart disease 18-32 years of age
No interventions assigned to this group
controls
healthy peers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
32 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bea Latal
Prof. Bea Latal
References
Explore related publications, articles, or registry entries linked to this study.
Kessler N, Feldmann M, Schlosser L, Rometsch S, Brugger P, Kottke R, Knirsch W, Oxenius A, Greutmann M, Latal B. Structural brain abnormalities in adults with congenital heart disease: Prevalence and association with estimated intelligence quotient. Int J Cardiol. 2020 May 1;306:61-66. doi: 10.1016/j.ijcard.2020.02.061. Epub 2020 Feb 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GUCHZurich
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.